Additionally, there was no significant correlation of tumor PD-L1 at the 5% cut-point: 10 years PFS: 79% for tumor PD-L1 ≥ 5%, 73% for tumor PD-L1 < 5% (Figure 2A). The gene discussed is CD274; the disease is neoplasm.